全文获取类型
收费全文 | 2277篇 |
免费 | 127篇 |
国内免费 | 13篇 |
专业分类
耳鼻咽喉 | 48篇 |
儿科学 | 165篇 |
妇产科学 | 72篇 |
基础医学 | 305篇 |
口腔科学 | 29篇 |
临床医学 | 139篇 |
内科学 | 551篇 |
皮肤病学 | 340篇 |
神经病学 | 92篇 |
特种医学 | 12篇 |
外科学 | 121篇 |
综合类 | 64篇 |
预防医学 | 38篇 |
眼科学 | 113篇 |
药学 | 295篇 |
中国医学 | 6篇 |
肿瘤学 | 27篇 |
出版年
2024年 | 3篇 |
2023年 | 36篇 |
2022年 | 43篇 |
2021年 | 60篇 |
2020年 | 99篇 |
2019年 | 92篇 |
2018年 | 90篇 |
2017年 | 87篇 |
2016年 | 64篇 |
2015年 | 68篇 |
2014年 | 110篇 |
2013年 | 291篇 |
2012年 | 70篇 |
2011年 | 88篇 |
2010年 | 62篇 |
2009年 | 76篇 |
2008年 | 85篇 |
2007年 | 88篇 |
2006年 | 89篇 |
2005年 | 69篇 |
2004年 | 48篇 |
2003年 | 72篇 |
2002年 | 70篇 |
2001年 | 59篇 |
2000年 | 50篇 |
1999年 | 55篇 |
1998年 | 38篇 |
1997年 | 41篇 |
1996年 | 39篇 |
1995年 | 28篇 |
1994年 | 24篇 |
1993年 | 24篇 |
1992年 | 25篇 |
1991年 | 21篇 |
1990年 | 23篇 |
1989年 | 10篇 |
1988年 | 18篇 |
1987年 | 12篇 |
1986年 | 9篇 |
1985年 | 10篇 |
1984年 | 12篇 |
1983年 | 6篇 |
1982年 | 6篇 |
1981年 | 13篇 |
1980年 | 8篇 |
1979年 | 3篇 |
1978年 | 6篇 |
1977年 | 3篇 |
1976年 | 6篇 |
1968年 | 2篇 |
排序方式: 共有2417条查询结果,搜索用时 15 毫秒
91.
Triple inhaled therapy for chronic obstructive pulmonary disease (COPD) consists of an inhaled corticosteroid (ICS), a long-acting β2-agonist (LABA) and a long-acting muscarinic antagonist (LAMA) taken in combination. Triple therapy is recommended by the Global initiative for Chronic Obstructive Lung Disease (GOLD) for patients who experience recurrent exacerbations despite treatment with either a dual bronchodilator (preferred initial therapy) or LABA/ICS combination (alternative initial therapy). Although there is evidence for the greater efficacy of triple therapy compared with LABA/ICS and LAMA monotherapy with regards to improved lung function, health status, and exacerbation rate, the efficacy of triple therapy when compared with dual bronchodilation (LABA/LAMA) is as yet unknown. As ICS use is associated with an increased risk of developing pneumonia, it is important to assess the risk/benefit ratio of triple therapy on an individual basis, and identify patients most likely to benefit. The role of elevated blood eosinophils as a biomarker for the identification of candidates for ICS treatment is currently debated, and further prospective evidence is required. This review assesses evidence for the efficacy and safety of triple therapy and postulates on the prospective evidence from ongoing studies. The potential for treating patients who experience further exacerbations on dual bronchodilation according to phenotype is also considered, as well as withdrawal of ICS from triple therapy in patients who are unlikely to benefit. 相似文献
92.
支气管哮喘患者吸入激素治疗依从性分析 总被引:7,自引:0,他引:7
[目的]了解支气管哮喘患者吸入糖皮质激素的依从性及其影响因素。[方法]对23例哮喘患者进行门诊问卷调查。[结果]23例中仅有4例基本遵从医嘱。其余19例均有不同程度的不遵从医嘱现象。平均依从率17.39%。影响因素包括恐惧激素、用药方法不当及用药副作用、经济困难、过早停药或间断用药等。大多数患者均对哮喘相关知识缺乏认识。[结论]应对哮喘患者进行长期系统的教育和管理、丰富患者的哮喘知识及加强对患者对激素应用的认识,是提高哮喘患者对激素吸入依从性的关键。 相似文献
93.
A. E. Stoop H. A. M. D. van der Heijden J. Biewenga S. van der Baan 《European archives of oto-rhino-laryngology》1992,249(6):313-317
Summary Clinical parameters of 72 patients who were operated upon for nasal polyps were evaluated as well as biopsy specimens of the mucosa of the middle and inferior turbinates of 41 of these patients. Biopsies were taken at the time of endoscopic sinus surgery (ESS), after 6 months and after 1 year in 23 patients. During the follow-up period the patients were treated with topical corticosteroids (budesonide). At the time of ESS significantly more CD8+ (suppressor/cytotoxic) cells than CD4+ (helper/inducer) cells were found in the middle and inferior turbinates. At 6 months significantly more CD4+ cells were found than at the time of ESS, whereas at 1 year the number of CD4+ cells had decreased and was lower than at 6 months. These data support the theory that the occurrence of nasal polyps is associated with T-cell-dependent disturbances. Clinical evaluation revealed that most of the patients with chronic airway obstruction had better pulmonary functions postoperatively or required less medication for lung disease. These findings show that ESS combined with topical corticosteroids has a positive effect on upper and lower respiratory tract pathology.
Correspondence to: A. E. Stoop 相似文献
94.
David Schiff 《Journal of neuro-oncology》1996,27(3):235-240
Summary We reviewed the clinical features and risk factors for Pneumocystis carinii pneumonia (PCP) in patients with brain tumors (BTs) seen at our institution between 1980 and 1992. Previously rare, this opportunistic infection appears to be increasing among HIV-negative cancer patients receiving immunosuppressive medications. Recent reports have noted PCP among BT patients receiving corticosteroids, and suggested that these patients are particularly likely to develop PCP when corticosteroids are tapered.Nine BT patients, eight with high-grade gliomas, experienced ten episodes of PCP None were known HIV-positive. All were on dexamethasone (DXM) at PCP onset, and had continuously been receiving it for 47–398 days (median 69). Daily DXM dose at PCP onset ranged from 1–16 mg (median 9). Five episodes occurred in patients receiving a stable DXM dose and five during DXM taper. Nine episodes occurred in patients receiving chemotherapy. All patients had absolute lymphopenia at PCP onset, ranging from 80–900 × 106 lymphocytes/l (median 222 × 106/l, normal > 1000 × 106). Three episodes were fatal despite appropriate antibiotic therapy.Unlike others, we did not find that corticosteroid taper predisposed to developing PCP As in HIV, PCP in BT patients appears related to lymphopenia, in these patients attributable to use and duration of corticosteroids and in some cases cytotoxic chemotherapy. Effective prophylaxis exists and should be considered for lymphopenic patients and those requiring DXM for > five weeks. 相似文献
95.
Behar-Cohen FF El Aouni A Gautier S David G Davis J Chapon P Parel JM 《Experimental eye research》2002,74(1):51-59
The major problems associated with the use of corticosteroids for the treatment of ocular diseases are their poor intraocular penetration to the posterior segment when administered locally and their secondary side effects when given systemically. To circumvent these problems more efficient methods and techniques of local delivery are being developed. The purposes of this study were: (1) to investigate the pharmacokinetics of intraocular penetration of hemisuccinate methyl prednisolone (HMP) after its delivery using the transscleral Coulomb controlled iontophoresis (CCI) system applied to the eye or after intravenous (i.v.) injection in the rabbit, (2) to test the safety of the CCI system for the treated eyes and (3) to compare the pharmacokinetic profiles of HMP intraocular distribution after CCI delivery to i.v. injection. For each parameter evaluated, six rabbit eyes were used. For the CCI system, two concentrations of HMP (62.5 and 150mg ml(-1)), various intensities of current and duration of treatment were analyzed. In rabbits serving as controls the HMP was infused in the CCI device but without applied electric current. For the i.v. delivery, HMP at 10mg kg(-1)as a 62.5mg ml(-1)solution was used. The rabbits were observed clinically for evidence of ocular toxicity. At various time points after the administration of drug, rabbits were killed and intraocular fluids and tissues were sampled for methylprednisolone (MP) concentrations by high pressure liquid chromatography (HPLC). Histology examinations were performed on six eyes of each group.Among groups that received CCI, the concentrations of MP increased in all ocular tissues and fluids in relation to the intensities of current used (0.4, 1.0 and 2.0mA/0.5cm(2)) and its duration (4 and 10min). Sustained and highest levels of MP were achieved in the choroid and the retina of rabbit eyes treated with the highest current and 10min duration of CCI. No clinical toxicity or histological lesions were observed following CCI. Negligible amounts of MP were found in ocular tissues in the CCI control group without application of current. Compared to i.v. administration, CCI achieved higher and more sustained tissue concentrations with negligible systemic absorption. These data demonstrate that high levels of MP can be safely achieved in intraocular tissues and fluids of the rabbit eye, using CCI. With this system, intraocular tissues levels of MP are higher than those achieved after i.v. injection. Furthermore, if needed, the drug levels achieved with CCI can be modulated as a function of current intensity and duration of treatment. CCI could therefore be used as an alternative method for the delivery of high levels of MP to the intraocular tissues of both the anterior and posterior segments. 相似文献
96.
97.
Zackheim HS 《Dermatologic therapy》2003,16(4):283-287
Experience at the University of California, San Francisco (UCSF), in the management of patch-stage mycosis fungoides (MF) with topical, predominantly high-potency, corticosteroids is reviewed. The technique of applications is discussed in detail. Approximately 200 patients have been treated. The results are very favorable. The response rate is over 90%. Side-effects are minor. Topical clobetasol is the first-line treatment for early stage MF at UCSF. 相似文献
98.
Severe acute respiratory syndrome (SARS) in Hong Kong 总被引:2,自引:0,他引:2
Severe acute respiratory syndrome (SARS) is a recently recognized and highly contagious pneumonic illness, caused by a novel coronavirus. While developments in diagnostic, clinical and other aspects of SARS research are well underway, there is still great difficulty for frontline clinicians as validated rapid diagnostic tests or effective treatment regimens are lacking. This article attempts to summarize some of the recent developments in this newly recognized condition from the Asia Pacific perspective. 相似文献
99.
Atopic dermatitis: review of immunopathogenesis and advances in immunosuppressive therapy 总被引:1,自引:0,他引:1
This paper reviews the theories of the pathogenesis of atopic dermatitis (AD), with a particular emphasis on its immunopathogenesis. The contribution of predisposing factors, immunopathogenic factors and provoking factors in the pathogenesis of AD are considered. Predisposing factors explored in this article include genetics and the disturbance of skin function. Immunopathogenic factors reviewed include T cell dysfunction, biphasic cytokine expression and the role of immunoglobulin E. Provoking factors considered include microbial factors, psychosomatic interactions, contact allergens and irritants, inhalant allergens, food and climate. Immunosuppressive treatments reviewed include cyclosporin, azathioprine, methotrexate, tacrolimus, interferon-gamma, phosphodiesterase inhibitors and pimecrolimus (SDZ ASM 981). 相似文献
100.
JA BATCH 《Journal of paediatrics and child health》1996,32(4):278-280
Abstract: Evidence exists for a potential role for inhaled corticosteroids, particularly when used in high dose to cause growth impairment, delayed maturation and adrenal suppression in children and adolescents with asthma. The functional significance of biochemical adrenal suppression remains uncertain. Similarly, there is as yet insufficient evidence to determine whether inhaled corticosteroids may adversely affect bone mineral density in children and adolescents with asthma. 相似文献